41959-29-9

Basic information

• Product Name: 2-Benzyl-6-hydroxy-2-azabicyclo[2.2.2]octane
• Synonyms: 2-Benzyl-6-hydroxy-2-azabicyclo[2.2.2]octane
• CAS NO: 41959-29-9
• Molecular Formula: C₁₄H₁₉NO
• Molecular Weight: 217.30676
• Mol File: 41959-29-9.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 332.4±25.0 °C(Predicted)
• Appearance: /
• Density: 1.147±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 14.78±0.20(Predicted)
• CAS DataBase Reference: 2-Benzyl-6-hydroxy-2-azabicyclo[2.2.2]octane(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Benzyl-6-hydroxy-2-azabicyclo[2.2.2]octane(41959-29-9)
• EPA Substance Registry System: 2-Benzyl-6-hydroxy-2-azabicyclo[2.2.2]octane(41959-29-9)

Safety Data

• Hazardous Substances Data: 41959-29-9(Hazardous Substances Data)

Usage

General Description

2-Benzyl-6-hydroxy-2-azabicyclo[2.2.2]octane is a chemical compound with a bicyclic structure and a benzyl and hydroxyl functional group. It is a derivative of the bicyclic compound azabicyclo[2.2.2]octane, which is commonly found in various drugs and pharmaceuticals. The presence of the benzyl group indicates that it is a derivative of benzene, a common aromatic hydrocarbon. The hydroxyl group suggests that it is a type of alcohol. 2-Benzyl-6-hydroxy-2-azabicyclo[2.2.2]octane may have potential applications in the pharmaceutical and chemical industries due to its unique structure and functional groups. Further research and testing may uncover its potential uses and properties.

Upstream product

• 10028-34-9 2-benzyl-2-aza-bicyclo[2.2.2]octane-3,6-dione 
• 41088-52-2 methyl 7-oxabicyclo[4.1.0]heptane-3-carboxylate 
• 100-46-9 benzylamine 
• 38025-71-7 2-benzyl-6-hydroxy-2-aza-bicyclo[2.2.2]octan-3-one 
• 79-37-8 oxalyl dichloride 
• 74403-57-9 2-benzyl-2-aza-bicyclo[2.2.2]octan-3-one 
• 67-68-5 dimethyl sulfoxide 

Relevant articles and documents

Certain 1-azabicyclo[2.2.1]heptanes useful as muscarinic receptor antagonists

MUSCARINIC RECEPTOR ANTAGONISTS OF THE FOLLOWING FORMULAE: STR1 Muscarinic receptor antagonists, useful especially in the treatment of irritable bowel syndrome, of formula (IA) or (IB) or a pharmaceutically acceptable salt thereof, where R 2 and R 3 are each independently H, halo or C 1 -C 4 alkyl; m is 0, 1 or 2; n is 1, 2 or 3; Y is a direct link, O or S; with the proviso that when n is 1, Y is a direct link; Het is a group of formula (A) or (B), where p is 0, 1 or 2, q is 1, 2 or 3, and r is 0, 1, 2 or 3, with the proviso that the sum of p, q and r is at least 3, the N atom of ""Het"" being attached to the group (CH 2) n in formula (IA) and to the H atom in formula (IB); and R 1 is a group of formula (a), (b) or Het 1, where R 4 and R 5 are each independently H, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, --(CH 2) t OH, halo, trifluoromethyl, cyano, --(CH 2) t NR 6 R 7, --CO(C 1 -C 4 alkyl), --OCO(C 1 -C 4 alkyl), CH(OH)(C 1 -C 4 alkyl), --C(OH)(C 1 -C 4 alkyl) 2, --SO 2 NH 2, --(CH 2) t CONR 6 R 7 or --(CH 2) t COO(C 1 -C 4 alkyl); R 6 and R 7 are each independently H or C 1 -C 4 alkyl; t is 0, 1 or 2; X and X 1 are each independently O or CH 2 ; s is 1, 2 or 3; and Het 1 is pyridyl, pyrazinyl or thienyl.